Literature DB >> 8442490

Results of penetrating keratoplasty in aniridia.

I Kremer1, R K Rajpal, C J Rapuano, E J Cohen, P R Laibson.   

Abstract

Eight aniridic patients with bilateral corneal scarring, vascularization, or edema underwent corneal transplantation in one or both eyes (11 eyes). Follow-up ranged from eight months to 5 1/2 years (average, three years). Six of 11 eyes (55%) had at least a two-line improvement in visual acuity and eight of 11 (73%) had at least one line of improvement. Best-corrected visual acuity was 20/200 or worse in nine of 11 eyes (82%), however. Postoperative complications included whorl keratopathy, persistent epithelial defects, central subepithelial scarring, peripheral vascularization with pannus, and graft rejection. Glaucoma was well controlled medically but five of nine patients (56%) with preexisting glaucoma needed an increase in medication for intraocular pressure control. Graft rejection occurred in seven of 11 eyes (64%) and three of these eyes required repeat transplantation.

Entities:  

Mesh:

Year:  1993        PMID: 8442490     DOI: 10.1016/s0002-9394(14)73581-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Boston type 1 keratoprosthesis: the New York Eye and Ear experience.

Authors:  A P Patel; E I Wu; D C Ritterband; J A Seedor
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

2.  Management of Congenital Aniridia-Associated Keratopathy: Long-Term Outcomes from a Tertiary Referral Center.

Authors:  Ghasem Yazdanpanah; Kelley J Bohm; Omar M Hassan; Faris I Karas; Abdelrahman M Elhusseiny; Manachai Nonpassopon; Muanploy Niparugs; Elmer Y Tu; Joel Sugar; Mark I Rosenblatt; Maria S Cortina; Ali R Djalilian
Journal:  Am J Ophthalmol       Date:  2019-11-12       Impact factor: 5.258

Review 3.  The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis.

Authors:  Steven Bonneau; C Maya Tong; Yelin Yang; Mona Harissi-Dagher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-04-06       Impact factor: 3.535

4.  Clinical outcomes and visual prognostic factors in congenital aniridia.

Authors:  Adam Jacobson; Shahzad I Mian; Brenda L Bohnsack
Journal:  BMC Ophthalmol       Date:  2022-05-25       Impact factor: 2.086

5.  Bilateral sporadic aniridia: review of management.

Authors:  Caroline O Adeoti; Adebimpe A Afolabi; Adeyinka A Afolabi; Adeyinka O Ashaye; Adebimpe O Ashaye; Adenike O Adeoye
Journal:  Clin Ophthalmol       Date:  2010-10-05

6.  Outcomes of the Boston keratoprosthesis in jordan.

Authors:  Wisam A Shihadeh; Hasan M Mohidat
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

7.  Keratopathy, cataract, and dry eye in a survey of aniridia subjects.

Authors:  David Shiple; Brenton Finklea; James D Lauderdale; Peter A Netland
Journal:  Clin Ophthalmol       Date:  2015-02-10

8.  Quantitative Analysis of the Association Between Follow-Up Duration and Severity of Limbal Stem Cell Deficiency or Visual Acuity in Aniridia.

Authors:  Shimpei Komoto; Yoshinori Oie; Satoshi Kawasaki; Ryo Kawasaki; Nozomi Nishida; Takeshi Soma; Shizuka Koh; Kazuichi Maruyama; Shinichi Usui; Kenji Matsushita; Motokazu Tsujikawa; Naoyuki Maeda; Kohji Nishida
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

Review 9.  Clinical and molecular aspects of congenital aniridia - A review of current concepts.

Authors:  Shailja Tibrewal; Ria Ratna; Abha Gour; Sumita Agarkar; Suneeta Dubey; Suma Ganesh; Ramesh Kekunnaya; Virender Sangwan; Yutao Liu; Vanita Vanita
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.